Kiniksa Pharmaceuticals
The Group Vice President, Global Regulatory Affairs provides enterprise-level regulatory leadership across Kiniksa Pharmaceuticals' development and commercial portfolio, shaping global regulatory strategy from early development through approval and lifecycle management. This senior leader serves as a strategic advisor to executive leadership and cross-functional teams, providing regulatory perspective on portfolio strategy, development pathways, and risk. The role involves leading global regulatory strategy for biologic programs, managing Health Authority interactions, and overseeing the Global Regulatory Affairs organization.
Kiniksa Pharmaceuticals is a biopharmaceutical company that believes every second makes a difference for patients living with debilitating diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kiniksa Pharmaceuticals.
Director, Global Regulatory Strategy Lead - Regulatory Affairs
Olema Oncology
Senior Vice President, Regulatory Affairs
Vir Biotechnology
Director, Global Regulatory Strategy Lead - Regulatory Affairs
Olema Oncology
Regulatory Affairs Lead
BeOne Medicines
Vice President, US Regulatory Affairs
ITF Therapeutics
Senior Director of Regulatory Affairs
ardelyx